-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Zynerba Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2016 to Q2 2023.
- Zynerba Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2023 was -90 %, a 62.2% decline year-over-year.
- Zynerba Pharmaceuticals, Inc. annual Return On Equity for 2022 was -63.3 %, a 41.3% decline from 2021.
- Zynerba Pharmaceuticals, Inc. annual Return On Equity for 2021 was -44.8 %, a 41.7% increase from 2020.
- Zynerba Pharmaceuticals, Inc. annual Return On Equity for 2020 was -76.8 %, a 83.2% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)